Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1999
10/05/1999US5962422 Inhibition of selectin binding
10/05/1999US5962335 Determining theraputic dosage regimen of drug by labeling drug with endogenous non-radioactive isotope and measuring isotope concentration before and after administration of drug; difference in values provides metabolism information
10/05/1999US5962220 St receptor binding moieties bind to the st receptor which is found on human colon cells. the invention relates to antisense compositions specifically targeted to colon cells.
10/05/1999US5962216 Tumor-activated prodrug compounds and treatment
10/05/1999US5962024 Peroral composition for controlled release in the lower gastrointestinal tract
10/05/1999US5962019 Alkanol solvent of from 2 to 3 carbon atoms in combination with at least one non-ionic surfactant.
10/05/1999US5962017 Pharmaceutical compositions comprising cyclosporins
10/05/1999US5962016 Multivesicular liposomes utilizing neutral lipids to modify in vivo release
10/05/1999US5962014 Hydrophilic component other than the hydrophilic surfactant, lipophilic component and hydrophilic surfactant other than the hydrophilic component; upon dilution with water an oil-in-water microemulsion is formed.
10/05/1999US5962012 Cholinergic antagonist patch
10/05/1999US5961993 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the treatment of acne
10/05/1999US5961979 Complex of a mammalian stress protein noncovalently associated with a peptide that is present in a eukaryotic cell infected with said pathogen but not present in said cell when said cell is not infected with said pathogen
10/05/1999US5961969 Enhancing natural killer cell cytotoxicity.
10/05/1999US5961459 Use of hollow microcapsules in diagnosis and therapy
10/05/1999CA2115884C Water-in-oil emulsion for use in cosmetics or in pharmaceutics
10/03/1999CA2265073A1 Compositions comprising copolymers of n-vinylcarboxamides and monomers with a hydrophobic radical, and the use of these compounds
09/1999
09/30/1999WO1999049019A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
09/30/1999WO1999048914A1 Methods for using heat shock proteins
09/30/1999WO1999048901A2 Sucrose-n-alkyl-asparaginates, production and use thereof
09/30/1999WO1999048536A2 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
09/30/1999WO1999048535A1 Formulations for protection of peg-interferon alpha conjugates
09/30/1999WO1999048534A1 Methods and means for the treatment of immune related diseases
09/30/1999WO1999048533A1 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
09/30/1999WO1999048532A1 Medicinal compositions adhering to stomach/duodenum
09/30/1999WO1999048531A1 Remedies for hepatitis
09/30/1999WO1999048517A1 Pharmaceutical compositions for prolonged peptide release and preparation method
09/30/1999WO1999048515A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof
09/30/1999WO1999048495A1 Benzoates derivatives for inhibiting angiogenesis
09/30/1999WO1999048493A1 Transdermal therapeutic system (tts) containing oxybutynin
09/30/1999WO1999048485A1 Method of treating neuroma pain
09/30/1999WO1999048480A2 Method for the production of micro capsules
09/30/1999WO1999048479A1 Slow release microcapsules
09/30/1999WO1999048477A1 Topical hormonal composition with systemic effect
09/30/1999WO1999048476A1 Improved compositions for inhalation
09/30/1999WO1999048474A1 Pharmaceutical or cosmetic compositions containing photosensitizing substances
09/30/1999WO1999048468A1 Method for accelerated administration of carotenoid mixtures in serum and tissues
09/30/1999WO1999048386A1 Natural substance based agent
09/30/1999WO1999048372A1 Encapsulation of components into edible products
09/30/1999WO1999048361A1 Xylitol compositions for treating upper respiratory conditions
09/30/1999WO1999042134A3 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders
09/30/1999WO1999039741A3 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
09/30/1999WO1999038506A3 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction
09/30/1999WO1999038495A3 Controlled release delivery of peptide or protein
09/30/1999WO1999037788A3 Diagnosis and treatment of aur1 and/or aur2 related disorders
09/30/1999WO1999037337A3 Prostheses with associated growth factors
09/30/1999WO1999033853A3 Carbohydrates, useful in solid delivery systems
09/30/1999WO1999033492A9 Method for tissue perfusion
09/30/1999WO1999027897A9 Site-specific preparation of polyethylene glycol-grf conjugates
09/30/1999DE19906034A1 High-purity squalane useful in cosmetic and pharmaceutical products, as vaccine adjuvant, for coating condoms and hypodermic needles, etc.
09/30/1999DE19814014A1 Arzneipflanzentrockenextrakte Medicinal plant dry extracts
09/30/1999DE19812688A1 Solid dosage forms useful for slow release of drugs, fragrances, plant-treating agents, animal feed additives and food additives
09/30/1999CA2325584A1 Improved compositions for inhalation
09/30/1999CA2325554A1 Microcapsules having delayed release
09/30/1999CA2325550A1 Remedies for hepatitis
09/30/1999CA2325439A1 Methods and means for the treatment of immune related diseases
09/30/1999CA2325437A1 Preparation based on natural substances
09/30/1999CA2325420A1 Method for the production of microcapsules
09/30/1999CA2325396A1 Sucrose-n-alkyl-asparaginates, production and use thereof
09/30/1999CA2324648A1 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
09/30/1999CA2324616A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof
09/30/1999CA2324347A1 Benzoates derivatives for inhibiting angiogenesis
09/30/1999CA2291066A1 Local delivery of long lasting therapeutic agents
09/30/1999CA2233725A1 Hemoglobin-hydroxyethyl starch complexes
09/29/1999EP0945452A1 Sugar compounds, gelling agents, gelling agent compositions, processes for the preparation of them, and gel compositions
09/29/1999EP0945139A1 Methods and means for the treatment of immune related diseases such as Graft vs. Host disease
09/29/1999EP0945138A1 Transfection particles
09/29/1999EP0945137A1 Sustained-release pharmaceutical composition
09/29/1999EP0945132A2 Ibuprofen composition
09/29/1999EP0945131A1 Peroral drug suspension
09/29/1999EP0945130A2 Use of alpha-omega substituted oxyalkylated silicones in cosmetics and pharmaceuticals
09/29/1999EP0944675A1 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use
09/29/1999EP0944648A1 Glp-1 derivatives
09/29/1999EP0944400A1 Bioactive derivatives of camptothecin
09/29/1999EP0944399A2 Covalent polar lipid conjugates for targeting
09/29/1999EP0944398A1 Percutaneous delivery system
09/29/1999EP0944397A1 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances
09/29/1999EP0944394A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity
09/29/1999EP0944383A1 Pharmaceutical suspension systems
09/29/1999EP0804146B1 Polyglycerine polyricinoleates
09/29/1999EP0776199B1 Oestradiol transdermal therapeutic system comprising hygroscopic additives
09/29/1999EP0711140B1 Antifungal nail solution
09/29/1999CN1230220A Therapy for 'alpha'-galactosidase deficiency
09/29/1999CN1230178A Polydithiocarbamate-containing macromolecules and use thereof for therapeutic and diagnostic applications
09/29/1999CN1230123A Inclusion complex containing indole selective serotonin agonist
09/29/1999CN1230108A Temp. sensitive gel for sustained delivery of protein drugs
09/29/1999CN1229677A Composition and methods using nitroxides to avoid oxygen toxicity
09/29/1999CN1229676A Human growth hormone-containing aqueous pharmaceutical composition
09/29/1999CN1229648A Biological cream and its prepn. method
09/29/1999CN1229639A Cosmetic
09/28/1999US5959087 The ligand is preferably an antibody, f(ab) fragment, single domain antibody (dabs) single chain antibody or a serum binding protein.
09/28/1999US5959077 Conjugate of poly-l-lysine or poly-l-ornithine where side chain amino groups have lactose or galactose residues and antiviral residues; targeted drug delivery of viricides against hepatitis with reduced side effects
09/28/1999US5958979 Stabilized medicaments containing thyroid hormones
09/28/1999US5958971 Chemical compounds
09/28/1999US5958959 Administering 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)anilide or 2-cyano-3-hydroxy-n-(4-(trifluoromethyl)phenyl)-2-butenamide
09/28/1999US5958937 Pharmaceutical formulations of poorly water soluble camptothecin analogues and NMP
09/28/1999US5958915 Antibacterial composition for oral administration
09/28/1999US5958901 Delivery of anionic macromolecules into cells.
09/28/1999US5958708 The molecules of the invention are useful for diagnostics, prophylaxis and treatment of allergy.
09/28/1999US5958471 Product obtained by co-spray drying mixture of sorbitol, xylitol and mannitol dissolved in water, in air stream at elevated temperature
09/28/1999US5958461 Vaginal pharmaceutical compositions
1 ... 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 ... 1712